Hypoxia-Induced Interleukin-6 and Interleukin-8 Production Is Mediated by Platelet-Activating Factor and Platelet-Derived Growth Factor in Primary Human Lung Cells
- 1 October 1998
- journal article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 19 (4) , 653-661
- https://doi.org/10.1165/ajrcmb.19.4.3058
Abstract
Hypoxia has been shown to induce the expression of different growth factors, cytokines, and proinflammatory mediators, including platelet-derived growth factor (PDGF), interleukin-6 (IL-6), interleukin-8 (IL-8), and platelet-activating factor (PAF) in animal models. PAF and PDGF are thought to play important roles in vascular remodeling and have been shown to induce expression of IL-6 and IL-8 genes under normoxic conditions. We hypothesize that de novo synthesis of IL-6, IL-8, and cell proliferation is enhanced in human pulmonary cells under hypoxic cell culture conditions. We further assumed an important role of PAF and/or PDGF in hypoxia-induced cell activation. Using cultures of primary human pulmonary fibroblasts and pulmonary vascular smooth muscle cells (VSMC) we show that hypoxia (3% O2) induced transcription and translation of IL-6 (4- to 5-fold) and IL-8 (5- to 6-fold) in both cell types. Hypoxia-induced expression of IL-6 was suppressed by 50% to 60% in the presence of the PAF antagonist WEB2170, or neutralizing anti-PDGF antibodies. In addition, we demonstrate that hypoxia induces a threefold increase of cell proliferation of fibroblasts and a twofold increase of VSMC proliferation. Similar to the effect on IL-6 and IL-8 synthesis, WEB2170 or neutralizing anti-PDGF antibodies downregulated hypoxia-induced proliferation of fibroblasts and VSMC by 50%. Our data show that PAF and PDGF are important mediators for hypoxia-induced cell activation and cytokine release in the human lung. We therefore hypothesize that IL-6 and IL-8 contribute to the progression of lung diseases associated with hypoxia, and that both proinflammatory factors, PAF and PDGF, are involved in hypoxia-dependent expression of IL-6 and IL-8 in human pulmonary fibroblasts and VSMC.Keywords
This publication has 33 references indexed in Scilit:
- Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedemaEuropean Respiratory Journal, 1996
- Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor.The Journal of Experimental Medicine, 1996
- Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages.American Journal of Respiratory Cell and Molecular Biology, 1996
- Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells.Proceedings of the National Academy of Sciences, 1995
- Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells.Proceedings of the National Academy of Sciences, 1995
- Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival.The Journal of Experimental Medicine, 1994
- Hypoxia and endothelial-smooth muscle cell interactions in the lung.American Journal of Respiratory Cell and Molecular Biology, 1994
- Characterization of fibroblast mitogens and chemoattractants produced by endothelial cells exposed to hypoxia.American Journal of Respiratory Cell and Molecular Biology, 1994
- Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1American Journal of Physiology-Cell Physiology, 1993
- Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992